Lamivudine (150mg) + Stavudine (30mg)
Lamistar 150 mg/30 mg Tablet is used in the treatment of HIV infection.
1 Bottle of 60 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lamistar 150 mg/30 mg Tablet is to be taken empty stomach.
Take it preferably one hour before or 2 hours after food.
Lamistar 150 mg/30 mg Tablet is a combination of two anti-HIV medicines: Lamivudine and Stavudine. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Lamistar 150 mg/30 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Lamistar 150 mg/30 mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Lamistar 150 mg/30 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Lamistar 150 mg/30 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Lamistar 150 mg/30 mg Tablet may be needed. Please consult your doctor.
Lamistar 150 mg/30 mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Lamistar 150 mg/30 mg Tablet may not be needed in these patients. Please consult your doctor.
Inform your doctor if you develop any signs and symptoms of jaundice while taking Lamistar 150 mg/30 mg Tablet. You may need to stop taking this medicine.
